Skip to main navigation Skip to search Skip to main content

An investigation into fused filament fabrication for pharmaceutical manufacturing

Research output: Contribution to conference › Poster › peer-review

81 Downloads (Pure)

Abstract

In a modern world, what is the best way to deliver medicines to the patient? Human beings are an extremely diverse species with many different factors that can influence the behaviour of a drug within the body. Children are a perfect example of such variety. Doses are often prescribed based on body weight, and can vary greatly from infants to adolescents. With current ‘traditional’ manufacture of oral dose pharmaceuticals, generally only a limited number of doses are produced, leading to difficulties with appropriate dosing. The ability to manufacture personalised doses for these patients would be of great benefit both practically and financially, and may even lead to ‘point of care’ manufacture.
Original languageEnglish
Publication statusUnpublished - 7 Apr 2016
EventPBP 10th World Meeting in Pharmaceutics, Biopharmeceutics and Pharmaceutical Technology - SECC, Glasgow, United Kingdom
Duration: 4 Apr 2016 → 7 Apr 2016

Conference

ConferencePBP 10th World Meeting in Pharmaceutics, Biopharmeceutics and Pharmaceutical Technology
Country/TerritoryUnited Kingdom
CityGlasgow
Period4/04/16 → 7/04/16

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • pharmaceutical manufacturing
  • drug delivery
  • fused filament fabrication (FFF)
  • 3D tablets

Fingerprint

Dive into the research topics of 'An investigation into fused filament fabrication for pharmaceutical manufacturing'. Together they form a unique fingerprint.

Cite this